ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.70
      0.13%
      US Tech 100
      17,612.80
      0.00%
      Dow Jones
      38,884.26
      0.08%
      Brent Oil
      82.175
      -0.83%
      Bitcoin
      62,283.27
      -0.08%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. China SXT Pharmaceuticals Inc (SXTC)

      7. China SXT Pharmaceuticals Inc (SXTC) News

      SXTC

      China SXT Pharmaceuticals (SXTC)

      China SXT Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SXTC
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      01/11/20244:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      10/26/20234:05PMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      10/04/20238:30AMGlobeNewswire Inc.China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      07/31/20234:15PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      05/19/20235:17PMEdgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      05/10/20238:00AMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/29/20232:20PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/29/20231:50PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/27/20236:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      02/28/20234:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      02/24/20235:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      02/13/20234:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      12/23/20226:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      11/07/20228:00AMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      10/12/20228:46AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      09/27/20228:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      07/18/202211:02AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      05/18/202212:30PMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      05/13/20224:09PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      05/11/20224:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/24/20224:32PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/16/20224:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/16/20228:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/15/20224:07PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      03/14/202210:33PMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionNASDAQ:SXTCChina SXT Pharmaceuticals Inc
      01/21/20225:01PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      01/21/20226:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      01/20/202211:25AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
      01/20/202210:45AMGlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentNASDAQ:SXTCChina SXT Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:SXTC